Norbert G. Riedel's Insider Trades & SAST Disclosures
Norbert G. Riedel's most recent trade in Eton Pharmaceuticals Inc was a trade of 50,000 Common Stock done at an average price of $3.8 . Disclosure was reported to the exchange on Jan. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Norbert G. Riedel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.78 per share. | 03 Jan 2025 | 50,000 | 137,145 (0%) | 0% | 3.8 | 189,000 | Common Stock |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 50,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 27,400 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.58 per share. | 03 Jan 2025 | 27,400 | 87,145 (0%) | 0% | 3.6 | 98,092 | Common Stock |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.47 per share. | 03 Jan 2025 | 25,000 | 162,145 (0%) | 0% | 3.5 | 86,750 | Common Stock |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 25,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 3,731 | 6,806 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.35 per share. | 02 Aug 2024 | 1,484 | 5,322 (0%) | 0% | 111.3 | 165,243 | Ordinary Shares |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,461 | 56,553 | - | - | Common Stock | |
| Eton Pharmaceuticals Inc | Riedel Norbert G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 30,000 | 164,555 | - | - | Stock Option (Right to buy) | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 3,075 | 14,946 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 11 Aug 2023 | 1,241 | 13,705 (0%) | 0% | 138.2 | 171,454 | Ordinary Shares |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,780 | 13,780 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,282 | 46,092 | - | - | Common Stock | |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 25,000 | 134,555 | - | - | Stock Option (Right to buy) | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 8,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Sale of securities on an exchange or to another person at price $ 155.86 per share. | 05 Aug 2022 | 8,000 | 10,399 (0%) | 0% | 155.9 | 1,246,920 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.28 per share. | 05 Aug 2022 | 8,000 | 18,399 (0%) | 0% | 55.3 | 442,240 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,561 | 12,960 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Sale of securities on an exchange or to another person at price $ 152.32 per share. | 05 Aug 2022 | 1,089 | 11,871 (0%) | 0% | 152.3 | 165,877 | Ordinary Shares |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,459 | 23,459 | - | - | Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 50,000 | 109,555 | - | - | Stock Option (Right to buy) | |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 14,270 | 42,810 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 14,270 | 0 | - | - | Restricted Stock Units | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Sale of securities on an exchange or to another person at price $ 147.96 per share. | 06 Aug 2021 | 1,306 | 10,399 (0%) | 0% | 148.0 | 193,236 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 2,246 | 11,705 (0%) | 0% | 0 | Ordinary Shares | |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 58,003 | 58,003 | - | - | Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 19,655 | 59,555 | - | - | Stock Option (Right to buy) | |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 14,270 | 14,270 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Norbert G. Riedel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 14,270 | 28,540 | - | - | Common Stock | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 6,765 | 6,765 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 2,705 | 10,390 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Norbert G. Riedel | Director | Sale of securities on an exchange or to another person at price $ 125.87 per share. | 06 Aug 2020 | 931 | 9,459 (0%) | 0% | 125.9 | 117,186 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges